🦴

Bone Cancers

Our bone cancer program combines limb-salvage surgery innovation with targeted therapies for osteosarcoma, Ewing sarcoma, and chondrosarcoma.

Learn More

280+

Sarcoma cases managed annually

82%

Limb-salvage success rate

3,400+

Tissue bank specimens

Our Researchers

See all

Dr. Arvind Krishnamurthy

Clinical Trials & Statistical Unit

Dr. Ananya Sharma

Department of Molecular Oncology

Research Themes

Osteosarcoma Genomics

Whole-genome sequencing to identify copy number alterations and chromothripsis events driving chemoresistance in osteosarcoma.

Limb-Salvage Innovation

3D-printed custom prostheses and navigation-guided resection to maximise function after tumour removal.

Ewing Sarcoma Targeted Therapy

Evaluating IGF-1R inhibitors and EZH2 inhibitors as novel therapeutic approaches in relapsed Ewing sarcoma.

Clinical Trials

NCT06234517

Active

Regorafenib in Relapsed Osteosarcoma After First-Line Failure

PI: Dr. Mayilvahanan Bose

NCT06234518

Recruiting

3D-Printed Prosthesis vs Conventional Endoprosthesis in Limb Salvage

PI: Dr. Mayilvahanan Bose

Help Young Patients Beat Bone Cancer

Your support funds innovative limb-salvage surgery technologies and genomic research that give young bone cancer patients the best chance at a full, active life.

Donate Now